Cylene Pharmaceuticals - San Diego, California 92121

Cylene Pharmaceuticals is categorized under Commercial Medical Research in San Diego, CA .

Business Name: Cylene Pharmaceuticals
Contact Person: William Rice, Chief Executive Officer
Address: 5935 Cornerstone Court West # 100, San Diego, California 92121
Phone Number: (858) 875-5100
Annual Revenue (USD): Unknown
Founding Year: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 5417114
Share This Business:
Related Businesses: Medivas LLC - San Diego, CA 92121
Acea Biosciences Inc - San Diego, CA 92121
Bio-Quant Inc - San Diego, CA 92121
Krex Pharmaceuticals Inc - San Diego, CA 92121
Advanced Biodelivery Sciences - San Diego, CA 92121
S K S Ocular LLC - San Diego, CA 92121
Tenova Pharmaceuticals Inc - San Diego, CA 92121
Stemedica Cell Technology - San Diego, CA 92121
Gnf Commercial Systems - San Diego, CA 92121
Sage Bioventures Inc - San Diego, CA 92121
Rempex Pharmaceuticals Inc - San Diego, CA 92121
Biomedica Inc - San Diego, CA 92121
Helicon Therapeutics - San Diego, CA 92121
Celgene Research San Diego - San Diego, CA 92121
Targegen Inc - San Diego, CA 92121
Astute Medical Inc - San Diego, CA 92121

The company Cylene Pharmaceuticals provides B2B services in the form of Commercial Medical Research from its single location in California. 1 to 4 employees work for Cylene Pharmaceuticals, and the business now earns Unknown per annum.

Cylene Pharmaceuticals was launched in 1997 and is classified under SIC code and category 8731 , and NAICS number and grouping 5417114 . To contact Cylene Pharmaceuticals, please call William Rice, Chief Executive Officer with the phone number (858) 875-5100 or visit its single location at 5935 Cornerstone Court West # 100 in San Diego, California 92121.

The location of the single location can also be found using the coordinates 32.89549,-117.19087. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.